Rosanna Mancari

Gynecologic Oncology Group

Papers

1

Total Citations

181

H-Index

1

About

Rosanna Mancari is a leading figure in gynecologic oncology, with a primary focus on the clinical management of epithelial ovarian carcinoma. Her most impactful contribution is her co-authorship of the landmark ESMO Clinical Practice Guidelines for the diagnosis, treatment, and follow-up of newly diagnosed and relapsed epithelial ovarian carcinoma, a work that has garnered over 180 citations. This guideline has served as an essential, evidence-based roadmap for clinicians worldwide, standardizing care from initial diagnosis through complex relapse scenarios. Beyond this seminal work, Mancari’s research spans the optimization of surgical and chemotherapeutic strategies, aiming to improve survival outcomes and quality of life for patients battling this challenging disease. Her contributions are particularly valued for bridging the gap between cutting-edge clinical trials and practical, everyday oncology practice. With a career dedicated to advancing treatment protocols and shaping international consensus, Mancari remains a trusted authority whose work directly influences how ovarian cancer is managed across Europe and beyond.

Research Focus

Key Achievements

1
H-Index
1
Papers
181
Total Citations
181
Avg Citations/Paper
🏆 Most Cited Paper
Newly diagnosed and relapsed epithelial ovarian carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
181 citations · 2010
📈 Most Prolific Year: 2010 (1 Papers)
🤝 Key Collaborators: 7
🏛 Institutions: Gynecologic Oncology Group

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago